‘ixEngage’ simplifies and accelerates the connection to care
SAN FRANCISCO, Sept. 11, 2024 /PRNewswire/ — ixlayer, a healthcare technology platform serving biopharma, today unveiled ‘ixEngage’ – a direct-to-patient solution. The technology provides compliant infrastructure to connect biopharma clients to the full healthcare ecosystem–labs, patients, payments, providers and prescriptions–to deploy personalized, patient customer experience (Cx) programs that meet the highest industry safety standards. ixEngage is available now as a solution for biopharma companies looking to connect to patients with speed, transparency, precision and measurable impact.
For more information on ixEngage, visit ixlayer.com/bio-pharma/
At the heart of ixEngage is the patient. By accelerating a patient’s path to diagnosis in moving lab testing further up the patient journey and making it more convenient and accessible to connect with their physicians, patients get the care and therapies they need faster. This configurable solution seamlessly integrates into biopharma’s disease state awareness (DSA), educational and marketing campaigns for existing or new go-to-market strategies, making traditional campaigns more actionable and effective.
ixEngage builds upon ixlayer’s cloud-based platform which has powered over 1,100 nationwide programs and enabled over four million patient care journeys. The new solution provides biopharma with a turnkey approach to orchestrate comprehensive marketing campaigns that go further than before–arming patients with the information and lab data needed for more actionable conversations with their physicians.
Some of the options through ixEngage, include:
“We believe the future of biopharma success will hinge on more proactive, data-driven collaboration with patients,” said Pouria Sanae, CEO and Co-founder of ixlayer. “Developing a comprehensive, direct-to-patient program demands intricate logistics, often costing millions and years to establish. With ixEngage, pharmaceutical companies can expedite this process, strengthen marketing campaigns, link patients with essential medical care and pave the path for future success and improved patient outcomes.”
ixEngage meets the industry’s medical, legal, and regulatory requirements. In its ongoing commitment to innovation, ixlayer continues to develop new features and functionalities for ixEngage to better serve patients and improve health outcomes.
About ixlayer
ixlayer [pronounced: I-X-layer] is the leading provider of cloud-based platforms that power a seamless, end-to-end direct-to-patient healthcare experience. The name reflects our core strength: “i” for robust data and technology infrastructure and “x” for exceptional user experience. The ixlayer platform seamlessly integrates with all healthcare ecosystem partners, connecting biopharma with patients in a user-centric way. This proprietary technology accelerates the path to diagnoses, supports optimal care, drives operational efficiency, and improves health equity and outcomes for all. To date, ixlayer has activated over four million patient care journeys across more than 1,100 programs, simplifying the complex web of healthcare. Learn more at www.ixlayer.com.
SOURCE ixlayer
Comprehensive Platform Combines Masimo’s Industry-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Expand the Wear…
Planegg/Martinsried, September 14, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
RIYADH, Saudi Arabia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…
Updated data show consistent objective response rate of 40% and manageable safety profile in patients…
Treatment data were analyzed from 3,276 cases of patients with newly diagnosed EGFR mutant NSCLC…
Post-progression outcomes showed significant and sustained improvement for amivantamab plus chemotherapy versus chemotherapy alone1 BEERSE,…